Article Sidebar

PDF
Date Published: 17/10/2022
Abstract Views: 1191
Views PDF: 506
DOI: https://doi.org/10.51298/vmj.v519i1.3570
Issue
Vol. 519 No. 1 (2022)
Section
Các bài báo
How to Cite
Ngọc Tuấn, C. ., Hữu Hoàng, B. ., & Duy Thông, V. . (2022). ACUTE ON CHRONIC LIVER FAILURE: A SUCCESSFUL THERAPEUTIC PLASMA EXCHANGE CASE REPORT. Vietnam Medical Journal, 519(1). https://doi.org/10.51298/vmj.v519i1.3570

ACUTE ON CHRONIC LIVER FAILURE: A SUCCESSFUL THERAPEUTIC PLASMA EXCHANGE CASE REPORT

Cao Ngọc Tuấn1, Bùi Hữu Hoàng1,2, Võ Duy Thông1,3,
1 University Medical Center Ho Chi Minh City
2 University of Medicine and Pharmacy at Ho Chi Minh City
3 Cho Ray Hospital

Main Article Content

Abstract

Abstract: Acute-on-chronic liver failure (ACLF) is a serious complication in patients with chronic liver disease. The definition and criteria of acute on chronic liver failure differ between the West (European and American countries) and the East (Asia). Treatment of acute on chronic liver failure is mainly symptomatic and removing precipitating factors. The disease has a high mortality rate, often requiring liver transplantation or therapeutic plasma exchange. We report a 73 year-old male patient, diagnosed with acute-on-chronic liver failure, grade 2 (10 points) due to acute exacerbations of chronic hepatitis B, according to the Asian Pacific association for the study of the liver). The patient was hospitalized in a state of jaundice, lost appetite, fatigue, dark yellow urine. The patient poorly responsed to conventional treatment and he was treated with plasma exchange.

Article Details

Keywords

Acute on chronic liver failure, hepatitis B, plasma exchange

References

1. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013 Jun;144(7):1426–37, 1437.e1-9.
2. Kumar R, Mehta G, Jalan R. Acute-on-chronic liver failure. Clinical Medicine. 2020 Sep 1;20(5):501–4.
3. Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019 Jul 1;13(4):353–90.
4. Goudsmit B, Braat A, Tushuizen M,et al. Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure. JHEP reports : innovation in hepatology. 2021;
5. Huy Do S. Epidemiology of Hepatitis B and C Virus Infections and Liver Cancer in Vietnam. Euroasian J Hepatogastroenterol. 2015 Jun;5(1):49–51.
6. Xu L, Tu Z, Xu G, et al. Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: a novel mechanism of HBV reactivation following anticancer chemotherapy. Mol Med Rep. 2014 Apr;9(4):1345–50.
7. Huang M, Huang L. Reactivation of hepatitis C viral infection after treatment with infliximab. J Clin Gastroenterol. 2014 Feb;48(2):189–90.
8. Kribben A, Gerken G, Haag S,et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012 Apr;142(4):782-789.e3.
9. Chen T, Yang Z, Choudhury AK, et al. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region. Hepatol Int. 2019 Nov;13(6):695–705.
10. Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis, Semantic Scholar.[cited 2022 Aug 18];Available from:https:// www.semanticscholar. org/paper/ Characterization of Inflammatory Responsein LiverSol%C3% A9 Sol%C3%A0/ 7c8e53b1ae949ee9bfee8a949c350d130f1070c4
11. Stravitz RT, Lee WM. Acute liver failure. Lancet. 2019 Sep 7;394(10201):869–81.